
Infinity Pharma (INFI) Earnings Dates & Reports
Infinity Pharma (INFI) Most Recent Earnings
Report Date
Period EndingQ2 2023
Est. EPS-$0.12
Actual EPS-$0.11
EarningsBeat
Infinity Pharma (INFI) Earnings
View the latest Infinity Pharma (INFI) earnings report, listen to the earnings call, and analyze historical earnings performance with AI-powered insights.
Start investing in Infinity Pharma (INFI)
Order type
Buy in
Order amount
Est. shares
0 shares
Infinity Pharma (INFI) Earnings per Share (EPS) History
Signup for full accessBrowse free
Infinity Pharma (INFI) Latest Earnings
The value each INFI share was expected to gain vs. the value each share gained.
Infinity Pharma (INFI) reported its most recent earnings on for Q2 2023, posting earnings per share (EPS) of -$0.11. This exceeded analysts' expectations of -$0.12 by 8.33%, marking a Beat.
For comparison, Infinity Pharma reported EPS of -$0.13 in the same quarter last year.
The company is expected to announce its next earnings report on , with analysts projecting an EPS of $0.
Infinity Pharma (INFI) Earnings History
Infinity Pharma (INFI) Earnings Related Price Changes
Earnings announcements may impact a stock’s price. This table highlights the Infinity Pharma’s price movement by comparing the day-before and day-after prices of recent earnings reports, along with the percentage change.
| Report date | Price 1D before | Price 1D after | Change |
|---|---|---|---|
| — | — | — | |
| — | — | — | |
| — | — | — | |
| — | — | — |
Infinity Pharma (INFI) Earnings FAQs
Infinity Pharma (INFI) last reported earnings on Aug 10, 2023 for Q2 2023, posting an EPS of -$0.11, which Beat the estimate of -$0.12 by 8.33%.
For Q2 2023, Infinity Pharma (INFI) reported an EPS of -$0.11, exceeding analysts' estimate of -$0.12 by 8.33%.
For Q2 2023, Infinity Pharma (INFI) Beat expectations with an actual EPS of -$0.11 vs. an estimated EPS of -$0.12.
Following the last earnings report on Aug 10, 2023, Infinity Pharma (INFI)'s stock price moved — from — to —.
The next Infinity Pharma (INFI) earnings call is scheduled for Aug. 10, 2023, where executives will discuss financial results and outlook.